ERM (ezrin, radixin and moesin) proteins function as linkers between the actin cytoskeleton and the plasma membrane (reviewed in [1] [2] [3] ). In addition to this structural role, these proteins are highly regulatable making them ideal candidates to mediate important physiological events such as adhesion and membrane morphology [4] [5] [6] [7] 
An in vitro 'pulldown' assay was used to study the interaction between ezrin and fusion proteins of the CD44 cytoplasmic domain with glutathione-S-transferase (GST). GST-CD44, but not GST alone, associated with an 81 kDa protein from Madin-Darby canine kidney (MDCK; Figure 1a ), Swiss 3T3 fibroblast, human RPM-MC melanoma and human SW620 colonic carcinoma cells (data not shown) which reacted with the anti-ezrin antibody and co-migrated with an ezrin band detected in cell lysates (Figure 1a) . In order to map the ezrin-binding site in CD44, a series of large GST-CD44 deletion mutants were generated. Pulldown assays demonstrated that the mid (residues 316-345) and carboxy-terminal (residues 337-361) domains of the CD44 cytoplasmic tail were not required for ezrin binding but that deletion of the amino-terminal domain (residues 296-315) completely abolished the association with ezrin ( Figure 1a ). Smaller deletions within this membrane-proximal domain revealed that loss of residues 289-291, 301-305, 306-310 and 311-316 did not affect binding, but that deletion of either residues 289-295 or 296-300 resulted in a complete loss of associated ezrin (Figure 1b ). This membrane-proximal ezrin-binding site is completely conserved between species (reviewed in [18] ) and is found in all of the alternatively spliced CD44 isoforms (reviewed in [17] ). In addition, it is spatially removed from the principal site of CD44 phosphorylation at Ser325 [19, 20] . Together with the demonstration that nonphosphorylated bacterially expressed GST-CD44 constructs retain the ability to associate with ezrin, this suggests that phosphorylation of CD44 does not regulate ezrin binding.
To further characterize the ezrin-binding site, extensive mutagenesis was undertaken across R 292 RRCGQKKK 300 (in the single-letter amino-acid code). Mutation of the K 298 KK 300 residues resulted in impaired ezrin binding, with Ala298, Ala299/Ala300 and Gln298/Ile299/Asn300 mutants binding at 67%, 39% and < 5%, respectively, of levels bound by the wild-type CD44 cytoplasmic domain (Figure 1c) . A similar binding profile was also observed for radixin (data not shown). Recently, Yonemura et al. [21] also demonstrated a requirement for K 298 KK 300 in CD44, and similar triads of basic amino acids in ICAM-2 and CD43, in the interaction with ERM proteins. In contrast to these studies, we also demonstrate here that mutations within a second cluster of basic residues, R 292 RR 294 , severely impair ERM binding, as the Ala292/Ala293 mutant bound undetectable levels of ezrin. Mutation of G 296 Q 297 to alanines, however, resulted in a mutant which bound ezrin at 108% of wild-type levels while an Ala294/Ala295 mutant bound with an efficiency of 87%. It remains to be determined whether additional residues within ICAM and CD43 are also required for efficient ERM binding. Alternatively, the presence of a second domain within the ERM-binding site, or the spacing of these domains, might be unique to CD44 and thereby function to generate binding specificity between the ERM proteins and their transmembrane partners.
Mutation of the CD44 ezrin-binding site does not impair hyaluronan binding or disrupt CD44 distribution
To investigate the role of ERM binding on CD44 function, we expressed full-length wild-type and ERM-bindingdeficient CD44 receptors in a CD44-negative RPM-MC human melanoma cell line. For these studies, the critical basic clusters within the ERM-binding site were mutated individually or in combination. In all cases, these mutations had no detectable effect on CD44 post-translational processing, as expressed proteins co-migrated with wild-type CD44 with a molecular mass of approximately 85 kDa (data not shown). It is well established that truncation of the CD44 cytoplasmic domain severely impairs hyaluronan binding [22] [23] [24] . Given that ERMs are cytoskeletally associated proteins, their interaction with CD44 might be expected to mediate efficient ligand binding by stabilizing the receptor in a hyaluronan-binding conformation. An investigation of this revealed that clonal lines expressing a severe ERM-binding mutant (CD44∆296-300) or a partial ERM-binding mutant (CD44-Ala298) displayed fluorescein isothiocyanate (FITC)-conjugated hyaluronan binding equivalent to wild-type CD44 ( Figure 2 ). Further analysis of RPM-MC cells expressing CD44-Ala292/Ala293/Ala294, CD44-Gln298/Ile299/Asn300 and CD44-Ala293/Ala294/Ala298/Ala299/Ala300 similarly revealed no reduction in hyaluronan binding (data not shown). These data are in agreement with those of Perschl et al. [22] , who proposed a model in which the stabilization of hyaluronan binding requires a minimal cytoplasmic domain region that is not dependent upon a specific amino acid sequence, rather than a model in which domains of the cytoplasmic tail regulate binding via association with cytoskeletal components.
In order to investigate whether an interaction with ERM proteins directs CD44 distribution in the plasma membrane, transfected cells were examined by confocal microscopy. In these cells, ezrin is closely associated with the plasma membrane in sites of cell-cell contact, ruffling edges, membrane projections and microvilli and there is a marked co-localization with CD44 (Figure 3a,b) . This distribution of ezrin is not mediated by its association with CD44, as in CD44-negative cells or cells expressing ERMbinding mutants, ezrin was observed clearly localized in the microvilli (Figure 3c -h) and other sites at which actin microfilaments closely associate with the plasma membrane (data not shown). This supports the evidence of Algrain et al. [25] that ezrin localization is predominantly regulated by its association with cytoskeletal components. In addition, mutation of the basic clusters, individually or in combination, had no effect on CD44 localization to membrane projections or ruffles (data not shown). Recently, it has been reported that an E-cadherin-CD44 chimaera containing a Gln298/Ile299/Asn300 ERMbinding mutation is impaired in its ability to localize to the microvilli [21] . Here, we have examined the microvillal localization of deletion and alanine-substitution mutant proteins and an equivalent Gln298/Ile299/Asn300 mutation
Figure 1
Mapping of the ezrin-binding site in CD44. Deletion and point mutations were generated by PCR using the high-fidelity Pfu polymerase (Stratagene). Wild-type CD44 cytoplasmic domain (residues 289-361) or cytoplasmicdomain mutants were ligated into the pGEX-KG vector, transformed into BL21(DE3)pLysS bacteria, and GST fusion proteins isolated on glutathione-agarose beads. For pulldown assays, MDCK cells were lysed in 10 mM HEPES pH 7.5, 1 mM MgCl 2 , 40 mM KCl, 1% Triton X-100, 1 mM PMSF for 15 min, cleared by centrifugation and incubated with fusion protein-glutathione-agarose beads for 1 h. Fusion proteins were eluted in nonreducing gel-loading buffer, resolved by SDS-PAGE, transferred onto nitrocellulose and probed with an anti-ezrin antibody [14] followed by horseradish-peroxidase-conjugated anti-rabbit immunoglobulin (Jackson Immunoresearch) and visualized by enhanced chemiluminescence. Left-hand panels show fusion constructs; right-hand panels show ezrin pulldown assays. Parallel gels were stained with Coomassie blue. Blots and gels were densitometrically scanned to quantitate relative levels of ezrin and GST fusion proteins. Molecular weights are in kDa. Lys in (a) represents 5 µl of MDCK cell lysate. 
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Current Biology generated in the full-length CD44 receptor. In all cases, CD44 mutant proteins were observed clearly co-localized with ezrin in the microvilli (Figure 3d-g ).
Our data would imply that although CD44 and ERM proteins can associate, neither plays a primary role in determining the localization of the other. Furthermore, these studies demonstrate that expression of CD44 in RPM-MC melanoma cells is not required for microvillus formation. It remains to be determined whether there is a role for transmembrane receptor-ERM interactions in defining the biogenesis/structure of microvilli and if so whether other ERM-binding proteins substitute for CD44 in CD44-negative cells. It is not known why the co-localisation studies shown in Figure 3 contradict those obtained by Yonemura et al. [21] , but these differences may result from the use of full-length functional CD44, which can bind hyaluronan, as opposed to chimeric CD44 constructs lacking the CD44 extracellular domain. Alternatively, differences may reflect cell-type-specific events such that mutant CD44 distribution may be differentially regulated in the CD44-negative RPM-MC cells and the L cells which contain endogenous murine CD44. It should be noted that although the two co-localization experiments were performed with ezrin and moesin respectively, both studies employed the CD44-Gln298/Ile299/Asn300 mutation, which is unable to bind either ERM protein. In contrast to the ERM-binding mutants, a CD44 construct truncated at Cys295 (tailless CD44) failed to localize to the microvilli (Figure 3h ), suggesting that there is an alternative, or additional, requirement outside the ERMbinding site for plasma membrane localization. In CD44, a di-hydrophobic motif at Leu331/Val332 has been identified as a polarized epithelial cell basolateral localization Brief Communication 707
Figure 2
CD44 containing mutations within the ERM-binding site bind hyaluronan with high efficiency. Mutations in full-length CD44 in the pSRα-neo eukaryotic expression vector were generated by PCR mutagenesis and transfected into the CD44-negative RPM-MC melanoma cell line as previously described [29] . Clonal RPM-MC lines were labelled with FITC-conjugated hyaluronan (FITC-HA), and CD44 was labelled with the monoclonal antibody E1/2 followed by biotinylated anti-mouse immunoglobulin and R-phycoerythrin avidin (CD44-PE) and analysed by two-colour flow cytometry [22, 23] motif [26] . It is not known, however, whether this has a role in regulating CD44 distribution in nonpolarized cells. Potentially more significant is the close proximity of the ERM-binding site to the transmembrane domain. The transmembrane domain is responsible for the observed CD44 Triton X-100 insolubility due to its ability to interact with glycolipid-enriched microdomains [27, 28] . One major function of glycolipid-enriched microdomains is to cluster key components of signal transduction pathways. It is tempting, therefore, to speculate that an association of ERM proteins at a site close to the CD44 transmembrane domain may function to regulate its subsequent interactions with downstream signalling pathways. In conclusion, the data presented here would suggest that ERM proteins are not key mediators of inside-out transmembrane receptor signalling, rather they are more probably candidates as regulators of outside-in signalling events.
